The COVID-19 vaccine made by U.S.-based Novavax can lead to the same types of heart inflammation that have occurred after vaccination with the Pfizer and Moderna shots, Europe’s drug regulator said on Aug. 3.
The European Medicines Agency said the vaccine, known as Nuvaxovid, should have myocarditis and pericarditis listed as side effects in the product information for the vaccine.
Prospective recipients and healthcare professionals should be warned about the issue, the organization said.
It has asked Novavax to provide additional data on the side effects.
Anaphylaxis, or severe allergic reaction, is already listed in Europe as a side effect of Nuvaxovid, which European regulators cleared in December 2021….